Chong Shan,Xiong Na'na,Fan Tengteng,Super-elderly treatment resistant depression patient treated with modified electroconvulsive therapy: a case report[J].SICHUAN MENTAL HEALTH,2025,38(1):84-88
Super-elderly treatment resistant depression patient treated with modified electroconvulsive therapy: a case report
DOI:10.11886/scjsws20240823001
English keywords:Modified electroconvulsive therapy  Super-elderly  Treatment-resistant depression  Maintenance treatment
Fund projects:国家重点研发计划项目(项目名称:脑深部电刺激治疗抑郁症安全性和有效性的动物研究,项目编号:2019YFC0118502)
Author NameAffiliationPostcode
Chong Shan Peking University Sixth Hospital Peking University Institute of Mental Health National Health Commission Key Laboratory of Mental Health (Peking University) National Clinical Research Center for Mental Disorders (Peking University Six Hospital) Beijing 100191 China 100191
Xiong Na'na Peking University Sixth Hospital Peking University Institute of Mental Health National Health Commission Key Laboratory of Mental Health (Peking University) National Clinical Research Center for Mental Disorders (Peking University Six Hospital) Beijing 100191 China 100191
Fan Tengteng* Peking University Sixth Hospital Peking University Institute of Mental Health National Health Commission Key Laboratory of Mental Health (Peking University) National Clinical Research Center for Mental Disorders (Peking University Six Hospital) Beijing 100191 China 100191
Hits:
Download times:
English abstract:
      The paper reported a case of super-elderly patient with treatment-resistant depression who underwent modified electroconvulsive therapy (MECT). The patient was an 87-year-old female presented to the hospital with an 8-year history of depressive disorder marked by intermittent episodes, who exhibited poor response to various antidepressants while achieved a significant improvement after receiving MECT. In the past two years, the patient experienced a recurrence of depression following life stress events. The condition showed improvement with the administration of MECT. However, after discontinuation of MECT, the depression relapsed multiple times, prompting rehospitalization for continued MECT to sustain clinical benefits. The patient demonstrated overall tolerable adherence to MECT. Based on research of domestic and international, this paper explored treatment options for super-elderly patients with treatment-resistant depression, aiming to provide insights into the application of MECT in the management of depression among super-elderly patients with depression. [Funded by National Key Research and Development Project (number, 2019YFC0118502)]
View Full Text   View/Add Comment  Download reader
Close